Table of Content

1 Valsartan Market Overview
1.1 Product Overview and Scope of Valsartan
1.2 Valsartan Segment by Type
1.2.1 Global Valsartan Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Valsartan Segment by Application
1.3.1 Global Valsartan Sales Comparison by Application: (2021-2027)
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Global Valsartan Market Size Estimates and Forecasts
1.4.1 Global Valsartan Revenue 2016-2027
1.4.2 Global Valsartan Sales 2016-2027
1.4.3 Valsartan Market Size by Region: 2016 Versus 2021 Versus 2027

2 Valsartan Market Competition by Manufacturers
2.1 Global Valsartan Sales Market Share by Manufacturers (2016-2021)
2.2 Global Valsartan Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Valsartan Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Valsartan Manufacturing Sites, Area Served, Product Type
2.5 Valsartan Market Competitive Situation and Trends
2.5.1 Valsartan Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Valsartan Players Market Share by Revenue
2.5.3 Global Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Valsartan Retrospective Market Scenario by Region
3.1 Global Valsartan Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Valsartan Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Valsartan Market Facts & Figures by Country
3.3.1 North America Valsartan Sales by Country
3.3.2 North America Valsartan Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Valsartan Market Facts & Figures by Country
3.4.1 Europe Valsartan Sales by Country
3.4.2 Europe Valsartan Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Valsartan Market Facts & Figures by Region
3.5.1 Asia Pacific Valsartan Sales by Region
3.5.2 Asia Pacific Valsartan Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Valsartan Market Facts & Figures by Country
3.6.1 Latin America Valsartan Sales by Country
3.6.2 Latin America Valsartan Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Valsartan Market Facts & Figures by Country
3.7.1 Middle East and Africa Valsartan Sales by Country
3.7.2 Middle East and Africa Valsartan Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Valsartan Historic Market Analysis by Type
4.1 Global Valsartan Sales Market Share by Type (2016-2021)
4.2 Global Valsartan Revenue Market Share by Type (2016-2021)
4.3 Global Valsartan Price by Type (2016-2021)

5 Global Valsartan Historic Market Analysis by Application
5.1 Global Valsartan Sales Market Share by Application (2016-2021)
5.2 Global Valsartan Revenue Market Share by Application (2016-2021)
5.3 Global Valsartan Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Valsartan Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sun Pharmaceutical Valsartan Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Valsartan Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Valsartan Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Alembic Pharmaceuticals Valsartan Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lupin Valsartan Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aurobindo Pharma Valsartan Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Macleods Pharmaceuticals Valsartan Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 HETERO
6.9.1 HETERO Corporation Information
6.9.2 HETERO Description and Business Overview
6.9.3 HETERO Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.9.4 HETERO Valsartan Product Portfolio
6.9.5 HETERO Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Corporation Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Torrent Pharmaceuticals Valsartan Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Huaren Pharmaceutical
6.11.1 Huaren Pharmaceutical Corporation Information
6.11.2 Huaren Pharmaceutical Valsartan Description and Business Overview
6.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Huaren Pharmaceutical Valsartan Product Portfolio
6.11.5 Huaren Pharmaceutical Recent Developments/Updates
6.12 Jubilant Pharma
6.12.1 Jubilant Pharma Corporation Information
6.12.2 Jubilant Pharma Valsartan Description and Business Overview
6.12.3 Jubilant Pharma Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Jubilant Pharma Valsartan Product Portfolio
6.12.5 Jubilant Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Corporation Information
6.13.2 Amneal Pharmaceuticals Valsartan Description and Business Overview
6.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Amneal Pharmaceuticals Valsartan Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Zhejiang Huahai Pharmaceutical
6.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.14.2 Zhejiang Huahai Pharmaceutical Valsartan Description and Business Overview
6.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
6.14.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.15 Square Pharmaceuticals
6.15.1 Square Pharmaceuticals Corporation Information
6.15.2 Square Pharmaceuticals Valsartan Description and Business Overview
6.15.3 Square Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Square Pharmaceuticals Valsartan Product Portfolio
6.15.5 Square Pharmaceuticals Recent Developments/Updates
6.16 Unichem Laboratories
6.16.1 Unichem Laboratories Corporation Information
6.16.2 Unichem Laboratories Valsartan Description and Business Overview
6.16.3 Unichem Laboratories Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Unichem Laboratories Valsartan Product Portfolio
6.16.5 Unichem Laboratories Recent Developments/Updates
6.17 LG Life Sciences
6.17.1 LG Life Sciences Corporation Information
6.17.2 LG Life Sciences Valsartan Description and Business Overview
6.17.3 LG Life Sciences Valsartan Sales, Revenue and Gross Margin (2016-2021)
6.17.4 LG Life Sciences Valsartan Product Portfolio
6.17.5 LG Life Sciences Recent Developments/Updates

7 Valsartan Manufacturing Cost Analysis
7.1 Valsartan Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Valsartan
7.4 Valsartan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Valsartan Distributors List
8.3 Valsartan Customers

9 Valsartan Market Dynamics
9.1 Valsartan Industry Trends
9.2 Valsartan Growth Drivers
9.3 Valsartan Market Challenges
9.4 Valsartan Market Restraints

10 Global Market Forecast
10.1 Valsartan Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Valsartan by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Valsartan by Type (2022-2027)
10.2 Valsartan Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Valsartan by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Valsartan by Application (2022-2027)
10.3 Valsartan Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Valsartan by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Valsartan by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Valsartan Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Valsartan Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Valsartan Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Valsartan Covered in This Study
Table 5. Global Valsartan Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Valsartan Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Valsartan Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Valsartan Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Valsartan Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Valsartan Manufacturing Sites and Area Served
Table 11. Manufacturers Valsartan Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Valsartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valsartan as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Valsartan Sales by Region (2016-2021) & (K Units)
Table 16. Global Valsartan Sales Market Share by Region (2016-2021)
Table 17. Global Valsartan Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Valsartan Sales by Country (2016-2021) & (K Units)
Table 19. North America Valsartan Sales Market Share by Country (2016-2021)
Table 20. North America Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Valsartan Revenue Market Share by Country (2016-2021)
Table 22. Europe Valsartan Sales by Country (2016-2021) & (K Units)
Table 23. Europe Valsartan Sales Market Share by Country (2016-2021)
Table 24. Europe Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Valsartan Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Valsartan Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Valsartan Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Valsartan Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Valsartan Revenue Market Share by Region (2016-2021)
Table 30. Latin America Valsartan Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Valsartan Sales Market Share by Country (2016-2021)
Table 32. Latin America Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Valsartan Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Valsartan Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Valsartan Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Valsartan Revenue Market Share by Country (2016-2021)
Table 38. Global Valsartan Sales (K Units) by Type (2016-2021)
Table 39. Global Valsartan Sales Market Share by Type (2016-2021)
Table 40. Global Valsartan Revenue (Million US$) by Type (2016-2021)
Table 41. Global Valsartan Revenue Share by Type (2016-2021)
Table 42. Global Valsartan Price (US$/Unit) by Type (2016-2021)
Table 43. Global Valsartan Sales (K Units) by Application (2016-2021)
Table 44. Global Valsartan Sales Market Share by Application (2016-2021)
Table 45. Global Valsartan Revenue (Million US$) by Application (2016-2021)
Table 46. Global Valsartan Revenue Share by Application (2016-2021)
Table 47. Global Valsartan Price (US$/Unit) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Novartis Valsartan Product
Table 52. Novartis Recent Developments/Updates
Table 53. Sun Pharmaceutical Corporation Information
Table 54. Sun Pharmaceutical Description and Business Overview
Table 55. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sun Pharmaceutical Valsartan Product
Table 57. Sun Pharmaceutical Recent Developments/Updates
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Teva Valsartan Product
Table 62. Teva Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Mylan Valsartan Product
Table 67. Mylan Recent Developments/Updates
Table 68. Alembic Pharmaceuticals Corporation Information
Table 69. Alembic Pharmaceuticals Description and Business Overview
Table 70. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Alembic Pharmaceuticals Valsartan Product
Table 72. Alembic Pharmaceuticals Recent Developments/Updates
Table 73. Lupin Corporation Information
Table 74. Lupin Description and Business Overview
Table 75. Lupin Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Lupin Valsartan Product
Table 77. Lupin Recent Developments/Updates
Table 78. Aurobindo Pharma Corporation Information
Table 79. Aurobindo Pharma Description and Business Overview
Table 80. Aurobindo Pharma Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Aurobindo Pharma Valsartan Product
Table 82. Aurobindo Pharma Recent Developments/Updates
Table 83. Macleods Pharmaceuticals Corporation Information
Table 84. Macleods Pharmaceuticals Description and Business Overview
Table 85. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Macleods Pharmaceuticals Valsartan Product
Table 87. Macleods Pharmaceuticals Recent Developments/Updates
Table 88. HETERO Corporation Information
Table 89. HETERO Description and Business Overview
Table 90. HETERO Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. HETERO Valsartan Product
Table 92. HETERO Recent Developments/Updates
Table 93. Torrent Pharmaceuticals Corporation Information
Table 94. Torrent Pharmaceuticals Description and Business Overview
Table 95. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Torrent Pharmaceuticals Valsartan Product
Table 97. Torrent Pharmaceuticals Recent Developments/Updates
Table 98. Huaren Pharmaceutical Corporation Information
Table 99. Huaren Pharmaceutical Description and Business Overview
Table 100. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Huaren Pharmaceutical Valsartan Product
Table 102. Huaren Pharmaceutical Recent Developments/Updates
Table 103. Jubilant Pharma Corporation Information
Table 104. Jubilant Pharma Description and Business Overview
Table 105. Jubilant Pharma Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Jubilant Pharma Valsartan Product
Table 107. Jubilant Pharma Recent Developments/Updates
Table 108. Amneal Pharmaceuticals Corporation Information
Table 109. Amneal Pharmaceuticals Description and Business Overview
Table 110. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Amneal Pharmaceuticals Valsartan Product
Table 112. Amneal Pharmaceuticals Recent Developments/Updates
Table 113. Zhejiang Huahai Pharmaceutical Corporation Information
Table 114. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 115. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Zhejiang Huahai Pharmaceutical Valsartan Product
Table 117. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 118. Square Pharmaceuticals Corporation Information
Table 119. Square Pharmaceuticals Description and Business Overview
Table 120. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Square Pharmaceuticals Valsartan Product
Table 122. Square Pharmaceuticals Recent Developments/Updates
Table 123. Unichem Laboratories Corporation Information
Table 124. Unichem Laboratories Description and Business Overview
Table 125. Unichem Laboratories Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Unichem Laboratories Valsartan Product
Table 127. Unichem Laboratories Recent Developments/Updates
Table 128. LG Life Sciences Corporation Information
Table 129. LG Life Sciences Description and Business Overview
Table 130. LG Life Sciences Valsartan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. LG Life Sciences Valsartan Product
Table 132. LG Life Sciences Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Valsartan Distributors List
Table 136. Valsartan Customers List
Table 137. Valsartan Market Trends
Table 138. Valsartan Growth Drivers
Table 139. Valsartan Market Challenges
Table 140. Valsartan Market Restraints
Table 141. Global Valsartan Sales Forecast by Type (2022-2027) & (K Units)
Table 142. Global Valsartan Sales Market Share Forecast by Type (2022-2027)
Table 143. Global Valsartan Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global Valsartan Revenue Market Share Forecast by Type (2022-2027)
Table 145. Global Valsartan Sales Forecast by Application (2022-2027) & (K Units)
Table 146. Global Valsartan Sales Market Share Forecast by Application (2022-2027)
Table 147. Global Valsartan Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. Global Valsartan Revenue Market Share Forecast by Application (2022-2027)
Table 149. Global Valsartan Sales Forecast by Region (2022-2027) & (K Units)
Table 150. Global Valsartan Sales Market Share Forecast by Region (2022-2027)
Table 151. Global Valsartan Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 152. Global Valsartan Revenue Market Share Forecast by Region (2022-2027)
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valsartan
Figure 2. Global Valsartan Market Share by Type in 2020 & 2027
Figure 3. 40 mg Tablets Product Picture
Figure 4. 80 mg Tablets Product Picture
Figure 5. 160 mg Tablets Product Picture
Figure 6. 320 mg Tablets Product Picture
Figure 7. Global Valsartan Market Share by Application in 2020 & 2027
Figure 8. Hypertension
Figure 9. Heart Failure
Figure 10. Heart Attack
Figure 11. Global Valsartan Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Valsartan Market Size 2016-2027 (US$ Million)
Figure 13. Global Valsartan Sales 2016-2027 (K Units)
Figure 14. Global Valsartan Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Valsartan Sales Share by Manufacturers in 2020
Figure 16. Global Valsartan Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Valsartan Players: Market Share by Revenue in 2020
Figure 18. Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Valsartan Sales Market Share by Region (2016-2021)
Figure 20. Global Valsartan Sales Market Share by Region in 2020
Figure 21. Global Valsartan Revenue Market Share by Region (2016-2021)
Figure 22. Global Valsartan Revenue Market Share by Region in 2020
Figure 23. United States Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Valsartan by Type (2016-2021)
Figure 46. Sales Market Share of Valsartan by Application (2016-2021)
Figure 47. Sales Market Share of Valsartan by Application in 2020
Figure 48. Revenue Share of Valsartan by Application (2016-2021)
Figure 49. Revenue Share of Valsartan by Application in 2020
Figure 50. Manufacturing Cost Structure of Valsartan
Figure 51. Manufacturing Process Analysis of Valsartan
Figure 52. Valsartan Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed